Enzymit

growth-positive

Enzymit, in partnership with NIZO, has successfully scaled up the production of novel enzymes using its proprietary cell-free manufacturing platform. This innovative technology allows for the creation of high-value biomolecules without the use of living cells, offering a sustainable alternative to traditional biomanufacturing methods. The collaboration marks a significant advancement in the industrialization of cell-free manufacturing, paving the way for broader adoption in various industries, including pharmaceuticals and cosmetics. The partnership leverages NIZOs expertise in protein expression and fermentation technologies and Enzymits cutting-edge enzyme design capabilities, showcasing a new, more efficient, and environmentally responsible approach to biomanufacturing.

growth-positive

Enzymit, an Israeli company recognized as a 2024 World Economic Forum Technology Pioneer, is advancing a cell-free bio-production technology aimed at transforming global manufacturing. By leveraging computational design and deep learning, Enzymit is engineering enzymes with enhanced stability and efficiency, offering a greener alternative to traditional chemical manufacturing. The company has raised $15 million and is collaborating with global partners to validate its synthetic hyaluronic acid for cosmetic and medical applications. Enzymits technology promises significant reductions in energy and water usage, supporting sustainable and localized production. The company is currently in the pilot stage, with plans to scale up production and expand into various markets.

growth-positive

Enzymit, an Israeli synthetic biology startup, has secured $10 million in a Series A funding round led by Grove Ventures and Khosla Ventures, with participation from First Star Ventures and Sapir Venture Partners. Founded in 2020, Enzymit is developing a cell-free production platform designed to make bioproduction faster, simpler, cost-effective, and scalable. The company uses computational design and deep learning to create novel enzymes optimized for cell-free systems, aiming to revolutionize bio-production. The funding will help establish a pilot facility and scale production for global distribution.

growth-positive

Enzymit, a biotechnology firm, is developing a safer method for detecting landmines by using bacteria. The companys CEO, Gideon Lapidoth, has partnered with a team at the Hebrew University of Jerusalem to engineer bacteria that glow in the presence of explosives. This innovative approach aims to reduce the risk to humans involved in landmine detection and removal.

growth-positive

Enzymit, a bioproduction platform company, has announced a breakthrough in landmine detection through the development of a protein-based biosensor. The company collaborated with researchers from the Hebrew University of Jerusalem to create a biosensing platform that can detect trace amounts of dinitrotoluene (DNT), a byproduct of TNT that leaks out of mines. The sensor is up to five times more sensitive and has a signal strength 30 times stronger than the original construct. The teams are currently working to further optimize the system and explore how the platform can be expanded to detect other hazardous materials.

growth-positive

Enzymit, an emerging enzyme engineering company, is using artificial intelligence to design enzymes that can produce human milk oligosaccharides (HMOs) more efficiently and at a lower cost. HMOs are critical for the development of an infants microbiome and are found in high concentrations in breast milk. However, they are difficult and expensive to produce for use in infant formula. Enzymits AI-based platform can predict enzyme structures that will perform known or novel functions, potentially reducing the cost of HMOs by 50%. This could lead to more affordable and nutritionally complete infant formulas.

growth-positive

Enzymit, a specialty biochemical company, has published a study demonstrating the efficacy of its deep learning-based technology for novel enzyme design. The study proposes an alternative approach to enzyme design by modifying existing enzymes to work with new molecules under different conditions. Enzymit developed two AI-based tools, CoSaNN and SolvIT, which enabled the creation of new enzymes with higher thermal stability and superior expression levels. The research highlights the transformative potential of AI in enzyme sequence design and its ability to create stable enzymes for a wide range of commercial applications. Enzymit is building a cell-free production platform to make bioproduction faster, simpler, cost-effective, and sustainable.

growth-positive

Biochemical company Enzymit has published a study demonstrating the effectiveness of its deep learning-based technology for novel enzyme design. The company has developed two AI-based tools, CoSaNN and SolvIT, for this purpose. CoSaNN uses deep learning to generate new enzyme conformations, enabling the redesigning of enzymes and new chemical reactions. SolvIT is a predictive model for protein solubility in E. coli, providing an additional layer of optimization for producing highly expressed enzymes. Using these tools, Enzymit created new enzymes with higher thermal stability and superior expression levels. The research highlights the potential of AI in enzyme sequence design.

growth-positive

Biochemical company Enzymit has announced the publication of a study demonstrating the effectiveness of its deep learning-based technology for novel enzyme design. The study proposes a new approach to enzyme design by modifying existing enzymes to work with new molecules under different conditions. This was achieved through the development of two new proprietary AI-based tools, CoSaNN and SolvIT. The tools enabled the creation of new enzymes with significantly higher thermal stability and superior expression levels compared to alternative methods.

growth-positive

Enzymit, a synthetic biology company, has developed an enzymatic process to create cell-free hyaluronic acid (HA) for cosmetics companies. The company claims that this process will reduce costs by up to 50% compared to traditional fermentation methods. Enzymits expertise in computational enzyme design and carbohydrate synthesis allowed them to achieve enzymatic bioproduction of HA with tailored molecular weights. The cell-free approach eliminates the need for complex downstream processing and enables more efficient production at scale. The article also mentions other developments in the beauty industry, such as Cambriums validated vegan collagen, Mixer & Packs RFID technology for fragrance production, snow fungus as an alternative to HA, and Kaffe Buenos coffee-based SPF booster.

growth-positive

Biochemical company Enzymit has announced its success in synthetically producing hyaluronic acid (HA) for use in cosmetic, aesthetic, and therapeutic applications using cell-free enzymatic manufacturing technology. This process reduces the complexity, time, and costs traditionally associated with HA production. The companys CEO, Gideon Lapidoth, stated that their cell-free approach significantly reduces overall costs and enables easier and more efficient production at scale. Enzymit is receiving interest from manufacturers looking to incorporate their HA variants into skincare products and is working to increase its production capacity.

growth-positive

Enzymit has successfully developed insulin substituents in partnership with Aleph Farms, which can reduce the cost and development time for producing cultivated meat at scale. The collaboration aims to create more suitable processing aids for the production of cultivated meat, driving economies of scale and cost-efficiency. The development of novel insulin substituents opens the door to benefits beyond cow cells, potentially influencing the production of other cultivated meat types. Enzymit utilized its computational design algorithms and testing capabilities to quickly develop a variety of insulin substituents, resulting in proteins that require fewer downstream purification and maturation processes, reducing production time and costs. Enzymit is a bioproduction platform company based in Israel, while Aleph Farms is a food technology company focused on sustainable animal product growth.

growth-positive

The article discusses the issue of plastic waste and the need for alternatives. It highlights a recent event called Disrupting the Future of Plastics, where start-ups presented innovative solutions. Biotic Circular Technologies emerged as the winner with its fully bio-based, fully biodegradable plastic alternative made from organic materials. The company aims to replace fossil-based plastics and reduce costs by at least 50%. They are in the final stages of moving into a pilot facility to scale production volumes. The article emphasizes the importance of finding alternatives to plastics and mentions Israels innovation ecosystem as a key player in the future of plastics.

growth-positive

Israeli startup Enzymit has developed computer algorithms to design enzymes for various industrial processes. The companys algorithms generate new enzyme sequences that can be used to create proteins with desired traits. Enzymit works with companies that print the DNA required for industrial production. The startup has already worked with a producer of hyaluronic acid and is currently developing enzymes for the production of prebiotics found in breast milk. Enzymit is also part of a consortium working on creating enzymes that can break down plastics. The companys technology has the potential to revolutionize various industries by simplifying and optimizing the production of chemicals and materials.

growth-positive

Hello Tomorrow’s Global Summit technology competition in Paris saw Sweetch Energy, a French start-up, win the €100,000 grand prize. The company generates emission-free energy using a nanoscale membrane that creates an electrical charge by exploiting the difference in salinity between river water and seawater. Other companies showcased included enaDyne, which uses nonthermal plasma catalysis to convert CO2 and a hydrogen source into chemicals and fuels, and New Iridium, which uses light-powered catalysts to make pharmaceuticals and other chemicals at low cost.

growth-positive

Enzymit, a bioproduction platform company, has been awarded ISO 9001:2015 certification for its design of novel enzymes and enzymatic processes. The certification demonstrates Enzymits commitment to quality management and customer satisfaction. Enzymit develops enzymes and enzymatic processes to make bioproduction faster, simpler, more cost-effective, and sustainable. The companys proprietary technology platform combines deep learning with computational design algorithms and high-throughput testing capabilities. Enzymit aims to serve a wide variety of markets and exceed customer expectations. The achievement of ISO 9001 certification is seen as a significant step towards realizing the goal of largescale cell-free bioproduction. Enzymit was founded in 2020 and is headquartered in Ness Ziona, Israel.

growth-positive

The article discusses the growth and investment trends in the digital health sector, highlighting the importance of innovation and sustainability in addressing public health challenges. Medika Life plans to visit various health innovation hot spots around the world. Tel Aviv, Israel is mentioned as a leading hub for health tech and ecohealth. The article also mentions several Israeli companies worth watching in the health tech sector. Overall, the article has a positive impact on Medika Life as it focuses on growth opportunities and highlights the companys involvement in the health innovation space.

growth-positive

Enzymit Inc., a syn-bio production platform company, has closed a $5 million seed round led by First Star Ventures. The company plans to use the investment to accelerate the development of its computational design platform and expand its product pipeline. Enzymits platform is based on enzymatic manufacturing and aims to replace inefficient and polluting chemical reactions used in modern production methods. The company is developing new-to-nature enzymes that can catalyze new reactions and outperform existing enzymes. Enzymit is also working on a novel enzymatic process to convert carbon from the air to bio-polymers. The bio revolution holds promise, and Enzymit aims to significantly impact the biomanufacturing industry and the global chemical market.